GI Research

Edmonton, Alberta T5H4B9

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Nonalcoholic Steatohepatitis

Studies at this site

• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed